Transurethral Incision Compared With Transurethral Resection of the Prostate for Bladder Outlet Obstruction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Yang, Qian; Peters, Tim; Donovan, Jenny; Tj, Wilt; Abrams, Paul

doi:10.1016/s0022-5347(05)66342-2

Cited by 83 publications

(45 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…46,47 The advantages of transurethral incision of the prostate (TUIP) are reduced bleeding with no need for postoperative irrigation and shortened catheterisation time together with a lower risk of developing retrograde ejaculation. 47 The disadvantage is that no prostatic tissue is removed leading to a high rate of symptom recurrence and need for further surgery. 51 These characteristics were improved by passing the Nd:YAG-generated beam through a potassium-titanyl-phosphate (KTP) crystal, which doubles the frequency and halves the wavelength.…”

mentioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

117

View full text Add to dashboard Cite

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Lourenco, T.; Armstrong, N.; N'Dow, J.; Nabi, G.; Deverill, M.; Pickard, R.; Vale, L.; MacLennan, G.; Fraser, C.; McClinton, S.; Wong, S.; Coutts, A.; Mowatt, G.; Grant, A. Published in: Health Technology Assessment Publication date: 2008 Document VersionPublisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA):Lourenco, T., Armstrong, N., N'Dow, J., Nabi, G., Deverill, M., Pickard, R., ... Grant, A. (2008). Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technology Assessment, 12(35). General rightsCopyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain.• You may freely distribute the URL identifying the publication in the public portal. Take down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 12. May. 2018 Health Technology Assessment 2008; Vol. 12: No. 35 Health Technology Assessment NIHR HTA Programme www.hta.ac.uk November 2008 Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £3...

show abstract

mentioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

117

View full text Add to dashboard Cite

show abstract

“…2 However, TUIP has significantly shorter operative time and hospital stay than TURP. [11][12][13][14] Nevertheless, there is little evidence on long-term effectiveness and there is no clear cutoff prostate size that achieves long-term favourable outcomes after TUIP.…”

Section: Discussionmentioning

confidence: 99%

“…3,15 Otherwise, meta-analysis and systematic reviews failed to detect improvement in symptom score after TUIP at 12 months compared to TURP. 1,2 This might be due to the high drop-out rates and the inconsistent patterns of evaluation of effectiveness.…”

Section: Discussionmentioning

confidence: 99%

“…Systematic reviews and meta-analyses confirm that TUIP has equivalent symptomatic improvement for men with prostate glands ± 30 mL, with the advantages of less morbidity, less bleeding and less sexual dysfunction than TURP. 1,2 Nevertheless, TUIP is underused due to its questionable long-term efficacy and lack of data. Without considering the prostate size limit, redo TURP was needed after a mean 16 months in 23.3% of patients who underwent TUIP.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Holmium laser transurethral incision of the prostate: Can prostate size predict the long-term outcome?

Elkoushy

Elshal

Elhilali

2015

CUAJ

View full text Add to dashboard Cite

Introduction:We determine the impact of prostate size on the long-term outcome of holmium laser transurethral incision of the prostate (Ho-TUIP) for bladder outlet obstruction (BOO) secondary to benign prostate enlargement (BPE). Methods: A retrospective review of prospectively collected data was performed for patients undergoing Ho-TUIP by a single surgeon for patients presenting with lower urinary tract symptoms (LUTS) secondary to BOO. Patients were stratified into 2 groups: Group 1 included patients with prostate ≤30 cc and Group 2 included patients with prostate >30 cc. Demographic, operative and followup data were recorded and analyzed. In addition, intraoperative and long-term adverse events were included. Results: In total, 82 patients underwent surgery between March 1998 and March 2013, including 9 (11%) reoperated patients. Only prostate size independently predicted reoperation after Ho-TUIP (adjusted odds ratio [aOR], 95% confidence interval [CI] 7.12 [2.92-9.14], p = 0.01). The receiver operating characteristic (ROC) analysis showed an optimal cutoff value of prostate volume of 29 cc to characterize long-term reoperation after TUIP, with area under the curve (AUC) of 0.96, sensitivity of 89.7 and specificity of 88.9. Group 1 included 51 patients and Group 2 included 31 patients. The international prostate symptoms score (IPSS) and peak flow rate (Qmax) significantly improved in both groups at different follow-up points. At the 12-month follow-up, the percent change in IPSS and Qmax were comparable between both groups. However, after 12 months, the degree of improvement in all voiding parameters was significantly higher in Group 1 (p < 0.001 at all points of follow-up). After a median follow-up of 5.3 years (range: 1-13), both groups had comparable early and late adverse events with significantly higher reoperation rate in Group 2 (3.9% vs. 22.6%, p = 0.02). Overall retrograde ejaculation was detected in 25.6% of sexually active men and it was comparable between both groups (23.5% vs. 29%, p = 0.61). On multivariable analysis, patients with prostate volume >30 cc were associated with significantly higher reoperation for BOO (aOR 95% CI 5.72 [2.83-8.14], p = 0.02), significantly higher IPSS (aOR 1.72), higher quality of life index (aOR 1.72) and lower Qmax (aOR 0.28). Conclusion: Ho-TUIP is a durable, safe and efficient treatment of BOO secondary to a small-sized prostate. The long-term outcome could be improved and the re-operation rate could be minimized with appropriate selection of cases, with prostate glands no bigger than 30 cc.

show abstract

“…These patients should experience symptom improvements similar to TURP with a lower incidence of retrograde ejaculation. 63 …”

Section: Transurethral Incision Of the Prostate (Tuip)mentioning

confidence: 99%

2010 Update: Guidelines for the management of benign prostatic hyperplasia

Nickel

Méndez-Probst

Whelan

et al. 2013

CUAJ

View full text Add to dashboard Cite

Transurethral Incision Compared With Transurethral Resection of the Prostate for Bladder Outlet Obstruction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cited by 83 publications

References 24 publications

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Holmium laser transurethral incision of the prostate: Can prostate size predict the long-term outcome?

2010 Update: Guidelines for the management of benign prostatic hyperplasia

Contact Info

Product

Resources

About